Halo Labs Inc. (“Halo”) has entered into a definitive share purchase agreement, (the “Share Purchase Agreement”) pursuant to which the Company, in exchange for up to 72,463,768 common shares of Halo (“Halo Shares”), will acquire all of the issued and outstanding shares of Canmart Ltd. (“Canmart”), a licensed importer and distributor of cannabis-based products in the United Kingdom. Issuance of certain Halo Shares will be subject to milestones and, once issued, will be subject to volume trading restrictions. In connection with the closing of the Acquisition, Halo also plans to issue an aggregate of 5,434,782 Halo Shares as a transaction fee to Anmoho LLC an arm’s length consultant of the Company. The Acquisition is expected to close on or before October 30, 2020, and is subject to the satisfaction or waiver of customary conditions.
Mmp News Author, Medical Marijuana Program Connection, 10/03/2020 04:41:34